Ocular motor assessment as an extension of the neurological examination in multiple sclerosis
Control subjects only, aged 35-65yo.
Cognitive function is highly prevalent in MS, however routine clinical assessment rarely includes assessment of cognitive function. This clearly impacts the implementation of effective patient management strategies. To address this, we propose the inclusion of ocular motor (OM) measures of cognition in the clinical assessment of MS patients. This research will ascertain the profile of measures most useful to possibly (1) aid diagnosis, and (2) measure disease progression. Ultimately this will lead to the development of a user-friendly, cost-effective, surrogate measure of brain damage and therapeutic effect which would dramatically improve patient management, potentially facilitating earlier identification of symptoms and progression and the prediction of disease course.